4/A
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-24-007711
Options or other derivatives
- Chief Medical Officer acquired 180,816 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Arbet-Engels Christophe Chief Medical Officer | 2024-02-13 | Grant or award · Stock Appreciation Right | +180,816 | 180,816 | D | ||
Loading xslF345X05/wk-form4a_1709160742.xml…